TRIPTYCH THERAPEUTICS Trademark

Trademark Overview

On Tuesday, March 11, 2025, a trademark application was filed for TRIPTYCH THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the TRIPTYCH THERAPEUTICS trademark a serial number of 99077321. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Tuesday, March 11, 2025. This trademark is owned by Triptych Therapeutics Management, Inc.. The TRIPTYCH THERAPEUTICS trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Therapeutic pharmaceuticals for the treatment of autoimmune, inflammatory, and allergic diseases; therapeutic pharmaceuticals and biological products for medical or clinical use for the treatment of autoimmune, inflammatory, and allergic diseases; biologics, namely, antibodies and antibody-containing polypeptide complexes for medical or clinical use for the treatment of autoimmune, inflammatory, and allergic diseases

Pharmaceutical research and development; research and development services of new pharmaceutical products; research and development in the pharmaceutical and biotechnology fields; research and development services for the treatment of autoimmune, inflammatory, and allergic diseases
triptych therapeutics

General Information

Serial Number99077321
Word MarkTRIPTYCH THERAPEUTICS
Filing DateTuesday, March 11, 2025
Status630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
Status DateTuesday, March 11, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesTherapeutic pharmaceuticals for the treatment of autoimmune, inflammatory, and allergic diseases; therapeutic pharmaceuticals and biological products for medical or clinical use for the treatment of autoimmune, inflammatory, and allergic diseases; biologics, namely, antibodies and antibody-containing polypeptide complexes for medical or clinical use for the treatment of autoimmune, inflammatory, and allergic diseases
Goods and ServicesPharmaceutical research and development; research and development services of new pharmaceutical products; research and development in the pharmaceutical and biotechnology fields; research and development services for the treatment of autoimmune, inflammatory, and allergic diseases

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, March 11, 2025
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, March 11, 2025
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameTriptych Therapeutics Management, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBoston, MA 02116

Trademark Events

Event DateEvent Description
Tuesday, March 11, 2025NEW APPLICATION ENTERED
Tuesday, March 11, 2025APPLICATION FILING RECEIPT MAILED
Thursday, July 10, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Related Keywords

therapeutics triptych diseases research development allergic inflammatory autoimmune treatment pharmaceutical services therapeutic